Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Matrixx Launches Zicam Products To Rebound During Cold Season

This article was originally published in The Tan Sheet

Executive Summary

Matrixx Initiatives says after weathering the storm of recalling two Zicam OTC homeopathic intranasal zinc-containing cold products, the firm's "real test" will come when the cold season reveals whether customers switch to oral delivery products
Advertisement

Related Content

FDA Warns Matrixx On Combination Supplement/Drug Products
FDA Warns Matrixx On Combination Supplement/Drug Products
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Trims Zicam Litigation Load To Focus on Personal Injury Claims
Matrixx Trims Zicam Litigation Load To Focus on Personal Injury Claims
To Rebuild Zicam, Matrixx Can Tap Into Brand's History, Pharmacists' Regard
Matrixx Banks On Oral Cold Remedies And A Severe Flu Season
Recall Strategy Crucial As Broader Awareness Leaves Firms Vulnerable
Zicam Case Shows FDA Takes Defining Adverse Events Seriously
Zicam Case Shows FDA Takes Defining Adverse Events Seriously

Topics

Advertisement
UsernamePublicRestriction

Register

PS103235

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel